Galera Therapeutics, Inc. (GRTX) Net income 2018–2025
Galera Therapeutics, Inc. (GRTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$149.0MFY2025 · since FY2018: -$23.7M → $149.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $149.0M | +886.2% |
| FY2024 | -$19.0M | +67.9% |
| FY2023 | -$59.1M | +5.0% |
| FY2022 | -$62.2M | +22.7% |
| FY2021 | -$80.5M | -8.5% |
| FY2020 | -$74.2M | -42.9% |
| FY2019 | -$51.9M | -119.3% |
| FY2018 | -$23.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice